Dan Nomura is a distinguished professor at UC Berkeley and an Investigator at the Innovative Genomics Institute, specializing in Chemical Biology and Molecular Therapeutics. He serves as the Director of the Novartis-Berkeley Translational Chemical Biology Institute and founded Frontier Medicines and Vicinitas Therapeutics. He’s also a16z Bio + Health’s newest advisory partner.
In this episode, Dan joins general partner Jorge Conde and investment partner Becky Pferdehirt to discuss how he got started working in chemical biology and chemoproteomics and his experience founding companies, along with leading lab and pharma collaborations.
Jorge Conde is a general partner on the Bio + Health team at Andreessen Horowitz, focused on therapeutics, diagnostics, life sciences tools, and software.
Dan Nomura Dan Nomura is an advisory partner on the a16z Bio + Health team.
Becky Pferdehirt is an investing partner on the Bio + Health team, focusing on early stage companies building technology platforms for therapeutic discovery and development.
Kris Tatiossian Kris Tatiossian, PhD, is the content lead on the Bio + Health team. She specializes in transforming complex scientific topics into accessible narratives. In this role, she oversees the brand’s digital strategy from podcasts, blogs, and newsletters to social media, bringing subjects like biotec...
Olivia Webb is the editorial lead, healthcare, on the Bio + Health team.
Between the growing ability to engineer biology for therapeutics, and the integration of tech into how patients receive care, bio and health are fundamentally changing the world. Join the team at a16z and host Olivia Webb as they discuss these transformations with scientists, builders, and leaders.